Amgen drug lowered cholesterol in hard-to-treat patients: studies
November 06 2012
Two Phase II studies indicate the experimental injectable can lower "bad" cholesterol among two hard-to-treat patient groups.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.